Citigroup Inc Day One Biopharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 48,070 shares of DAWN stock, worth $625,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,070

Previous 34,005 41.36%

Holding current value

$625,390

Previous $468,000 42.95%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$12.72 - $16.03 $178,906 - $225,461	14,065 Added 41.36%	48,070 $669,000
Q2 2024 Aug 12, 2024	SELL	$12.03 - $17.69 $1.65 Million - $2.42 Million	-137,045 Reduced 80.12%	34,005 $468,000
Q1 2024 May 10, 2024	BUY	$13.56 - $17.46 $964,455 - $1.24 Million	71,125 Added 71.18%	171,050 $2.83 Million
Q4 2023 Feb 09, 2024	SELL	$9.68 - $15.37 $7,163 - $11,373	-740 Reduced 0.74%	99,925 $1.46 Million
Q3 2023 Nov 09, 2023	BUY	$11.22 - $14.86 $47,505 - $62,917	4,234 Added 4.39%	100,665 $1.24 Million
Q2 2023 Aug 10, 2023	SELL	$11.74 - $14.47 $664,096 - $818,524	-56,567 Reduced 36.97%	96,431 $1.15 Million
Q1 2023 May 11, 2023	BUY	$12.75 - $23.41 $803,058 - $1.47 Million	62,985 Added 69.97%	152,998 $2.05 Million
Q4 2022 Feb 09, 2023	SELL	$18.77 - $22.0 $783,328 - $918,126	-41,733 Reduced 31.68%	90,013 $1.94 Million
Q3 2022 Nov 10, 2022	BUY	$16.44 - $26.57 $2.12 Million - $3.43 Million	128,981 Added 4664.77%	131,746 $2.64 Million
Q2 2022 Aug 10, 2022	BUY	$5.72 - $17.9 $3,214 - $10,059	562 Added 25.51%	2,765 $49,000
Q1 2022 May 12, 2022	SELL	$9.12 - $17.47 $22,608 - $43,308	-2,479 Reduced 52.95%	2,203 $22,000
Q4 2021 Feb 10, 2022	BUY	$15.65 - $26.33 $53,256 - $89,600	3,403 Added 266.07%	4,682 $79,000
Q3 2021 Nov 10, 2021	BUY	$20.0 - $27.92 $25,580 - $35,709	1,279 New	1,279 $30,000

Others Institutions Holding DAWN

# of Institutions

181

Shares Held

84.2M

Call Options Held

148K

Put Options Held

218K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $956M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account